Caxton Associates (New York)’s Cohen & Steers CNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-14,304
Closed -$829K 435
2023
Q2
$829K Sell
14,304
-9,617
-40% -$562K 0.12% 176
2023
Q1
$1.53M Buy
23,921
+10,337
+76% +$721K 0.23% 78
2022
Q4
$877K Buy
13,584
+3,576
+36% +$224K 0.06% 139
2022
Q3
$627K Buy
10,008
+969
+11% +$69.3K 0.08% 197
2022
Q2
$575K Sell
9,039
-2,920
-24% -$221K 0.06% 242
2022
Q1
$1.03M Buy
11,959
+5,239
+78% +$434K 0.08% 102
2021
Q4
$622K Sell
6,720
-351
-5% -$32.5K 0.06% 218
2021
Q3
$592K Buy
7,071
+2,779
+65% +$236K 0.07% 176
2021
Q2
$352K Sell
4,292
-5,822
-58% -$420K 0.04% 263
2021
Q1
$661K Buy
+10,114
New +$691K 0.06% 117
2020
Q4
Sell
-6,892
Closed -$384K 169
2020
Q3
$384K Buy
+6,892
New +$425K 0.04% 151

Other funds holding CNS

Caxton Associates (New York)'s CNS Position: Q3 2023 in Review

Caxton Associates (New York) sold out of Cohen & Steers (CNS) in Q3 2023, closing a stake of 14,304 shares — an estimated $829K sold.

Caxton Associates (New York) first reported a position in CNS in Q3 2020 and held it in 11 quarters. The position peaked at $1.53M in Q1 2023. 196 funds tracked by Wall St. Rank hold CNS as of Q3 2023.

  • Caxton Associates (New York) reported no remaining Cohen & Steers position as of Q3 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 14,304 Cohen & Steers shares in Q3 2023, an estimated $829K.
  • Caxton Associates (New York) first reported a position in Cohen & Steers in Q3 2020 and held it in 11 quarters.
  • Caxton Associates (New York)'s Cohen & Steers position peaked at $1.53M in Q1 2023.
  • 196 funds tracked by Wall St. Rank held Cohen & Steers as of Q3 2023.

Based on Caxton Associates (New York)'s 13F filing for Q3 2023, filed 14 Nov 2023.